quant Healthcare Fund holds 25 instruments (80.38% equity), led by GlaxoSmithKline Pharmaceuticals Limited (9.93%), Concord Biotech Limited (9.66%) and Zydus Wellness Limited (9.33%), as of its 31 July 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of quant Healthcare Fund, managed by quant Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 25 instruments with an equity allocation of 80.38%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
quant Healthcare Fund's top 10 holdings account for 77.41% of its portfolio, more concentrated than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 55.56% of net assets, spread across 4 sectors in total. Since its 30 June 2026 disclosure, the fund added 2 new positions and exited 1 position, with GlaxoSmithKline Pharmaceuticals Limited seeing the largest move (+7.89pp to 9.93%).
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| GlaxoSmithKline Pharmaceuticals Limited | 2.04% → 9.93% | ▲ +7.89 |
| Concord Biotech Limited | 8.84% → 9.66% | ▲ +0.82 |
| Pfizer Limited | 5.44% → 5.82% | ▲ +0.38 |
| Aster DM Healthcare Limited | 8.96% → 9.25% | ▲ +0.29 |
| Stock | Weight | Change |
|---|---|---|
| HFCL Limited | 10.76% → 7.89% | ▼ -2.87 |
| SMS Pharmaceuticals Limited | 8.15% → 7.27% | ▼ -0.88 |
| Strides Pharma Science Limited | 2.86% → 2.64% | ▼ -0.22 |
| Zydus Wellness Limited | 9.44% → 9.33% | ▼ -0.11 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).
| # | Holding | Sector | % to NAV |
|---|---|---|---|
| 1 | TREPS DEPO 10other | — | 11.59% |
| 2 | Divi's Laboratories Limitedother | — | 9.93% |
| 3 | GlaxoSmithKline Pharmaceuticals Limited | Healthcare | 9.93% |
| 4 | Concord Biotech Limited | Healthcare | 9.66% |
| 5 | Zydus Wellness Limited | Consumer Staples | 9.33% |
| 6 | Aster DM Healthcare Limited | Healthcare | 9.25% |
| 7 | Glenmark Pharmaceuticals Ltdother | — | 9.21% |
| 8 | HFCL Limited | Telecommunication | 7.89% |
| 9 | SMS Pharmaceuticals Limited | — | 7.27% |
| 10 | Alivus Life Sciences Limited | Healthcare | 7.19% |
| 11 | IPCA Laboratories Limited | Healthcare | 5.93% |
| 12 | Pfizer Limited | Healthcare | 5.82% |
| 13 | Aurobindo Pharma Limited | Healthcare | 5.14% |
| 14 | Strides Pharma Science Limited | Healthcare | 2.64% |
| 15 | 91 Days Treasury Billtbill | — | 0.75% |
| 16 | 91 Days Treasury Billstbill | — | 0.75% |
| 17 | 91 DAYS T-BILL - 20AUG2026tbill | — | 0.75% |
| 18 | 91 Days Treasury Billsbond | — | 0.75% |
| 19 | 91 Days Treasury Billtbill | — | 0.75% |
| 20 | 91 Days Treasury Billtbill | — | 0.75% |
| 21 | 91 Days Treasury Billstbill | — | 0.75% |
| 22 | 91 Days Treasury Billstbill | — | 0.75% |
| 23 | 91 Days Treasury Billtbill | — | 0.75% |
| 24 | Sumitomo Chemical India Limited | Materials | 0.33% |
| 25 | NCA-NET CURRENT ASSETSother | — | -17.89% |
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: quant Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.